Yi Sheng Pharmaceutical Industry (002566) February 28 evening announced the offer letter of intent, March 9 implementation of the purchase. The company intends to issue 27.6 million shares, the total share capital after the issuance of 110 million shares. The company under the network issue accounted for the number of the issue of 20%, that is, 5.52 million shares, the number of online distribution for the total amount of this issue minus the net under the final issue quantity, that is, 22.08 million shares. The company is mainly engaged in the development, production and sales of proprietary Chinese medicine. 2008 2010, the company realized operating income of 311 million yuan, 414 million yuan and 516 million yuan, the owner of the parent company's net profit is 41.3666 million yuan, 61.1287 million yuan and 87.6379 million yuan respectively.
The content source of this page is from Internet, which doesn't represent Alibaba Cloud's opinion;
products and services mentioned on that page don't have any relationship with Alibaba Cloud. If the
content of the page makes you feel confusing, please write us an email, we will handle the problem
within 5 days after receiving your email.
If you find any instances of plagiarism from the community, please send an email to:
info-contact@alibabacloud.com
and provide relevant evidence. A staff member will contact you within 5 working days.
